Expanding the leadership horizon

From total quality to total integration. From an Indian multinational to a global corporate. And from generic products, to a series of differentiated products...

At Ranbaxy, the ability to foresee and consequently capitalize on change, has enabled us to constantly expand the sphere of leadership. The year gone by has been a time of strategic consolidation and preparation for manifold growth and transformation, through scientific breakthroughs and strategic acquisitions & alliances. As the global pharmaceutical industry gears up to accelerate once again, Ranbaxy, with its thrust on end-to-end integration, is better prepared than ever before, to convert emerging opportunities into transformational successes.

Today, Ranbaxy is India’s largest pharmaceutical company; a Top 10 global generic player with a growing presence in 23 of the Top 25 pharma markets and is among the largest ANDA filers with the US FDA. But tomorrow is more promising, with a wide range of products in the pipeline, new acquisitions in strategic markets on the anvil and a clear target to achieve global sales of US $ 2 Bn by 2007. To attain a size of US $ 5 Bn by 2012 is within the realms of possibility, driven by passion and led by a vision that extends beyond tomorrow...